Privi Speciality Chemicals Reports Strong Q1 FY2026 Results, Targets Rs. 5,000 Crore Revenue by FY2029
Privi Speciality Chemicals announced robust Q1 FY2026 results, with consolidated revenue up 22% to Rs. 568.00 crores. EBITDA grew 45% to Rs. 141.00 crores, and profit after tax nearly doubled to Rs. 61.00 crores. Exports accounted for 70% of revenues. The company is pursuing a merger of subsidiaries and maintains a 20% annual growth guidance. A Rs. 1,100.00 crore capex plan is outlined for the next 2-3 years. Privi aims to achieve Rs. 5,000.00 crore in revenue and Rs. 1,000.00 crore in EBITDA within 3-5 years. The company earned a platinum rating from EcoVadis for ESG performance and is expanding production capabilities, expected to complete by March 2026.

*this image is generated using AI for illustrative purposes only.
Privi Speciality Chemicals , a leading manufacturer of aroma and specialty chemicals, has reported robust financial results for the first quarter of fiscal year 2026, demonstrating significant growth across key metrics.
Financial Highlights
The company reported a consolidated revenue of Rs. 568.00 crores for Q1 FY2026, marking a 22% year-over-year increase. EBITDA saw an impressive growth of 45%, reaching Rs. 141.00 crores, with margins expanding to 24.80% from 20.80% in the previous year. Profit after tax nearly doubled to Rs. 61.00 crores, up from Rs. 32.00 crores in the same quarter last year.
Export Performance and Capacity Utilization
Exports continued to be a strong contributor, accounting for approximately 70% of the company's revenues. Privi Speciality Chemicals reported optimal capacity utilization across all its products, indicating strong demand and operational efficiency.
Strategic Initiatives and Future Outlook
The company is pursuing a merger of Privi Fine Sciences and Privi Biotechnologies with Privi Speciality Chemicals, aimed at simplifying the corporate structure and unlocking synergies.
Mahesh Babani, Chairman & Managing Director, stated, "We are confident of making this into a Rs. 5,000 crore company together. That means Rs. 3,500-4,000 crore will be from Privi and about Rs. 1,000 to 1,200 crore will come from Privi Fine Science."
The management maintains its guidance of 20% annual growth and has set a target of achieving Rs. 5,000.00 crore in revenue and Rs. 1,000.00 crore in EBITDA within the next 3-5 years. To support this growth, the company has outlined a Rs. 1,100.00 crore capex plan over the next 2-3 years.
Product Development and Sustainability
Privi Speciality Chemicals is focusing on developing several super specialty aroma chemicals, which are currently at lab and pilot levels. The company serves the top 15 global customers in the fragrance and flavor industry and expects limited impact from US tariffs as US exports represent only 7% of its revenue.
Notably, the company has earned a platinum rating from EcoVadis, placing it in the top 1% globally for ESG performance. This achievement underscores Privi's commitment to sustainability and ethical business practices.
Expansion and New Products
The company is expanding its production capabilities, with the expansion expected to be completed by March 2026. Privi is also working on innovative products such as cyclopentanol, which will be produced from renewable sources and has applications in aroma chemicals, pharmaceuticals, and the electronic chip industry.
In conclusion, Privi Speciality Chemicals' strong Q1 FY2026 results, coupled with its strategic initiatives and focus on sustainability, position the company well for continued growth in the specialty chemicals sector. The management's confidence in achieving ambitious revenue and EBITDA targets reflects the company's strong market position and growth potential in the coming years.
Historical Stock Returns for Privi Speciality Chemicals
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-0.08% | +4.72% | +1.19% | +58.86% | +67.07% | +336.27% |